---
figid: PMC9280743__WJG-28-2937-g005
pmcid: PMC9280743
image_filename: WJG-28-2937-g005.jpg
figure_link: /pmc/articles/PMC9280743/figure/F5/
number: Figure 5
figure_title: ''
caption: 'The activity of fatty acid synthesis was enhanced in TM6SF2 knockdown group.
  A: Pathway enrichment of the up-regulated differentially expressed genes by Kyoto
  Encyclopedia of Genes and Genomes analysis; B: Microarray heatmap of genes involved
  in fatty acid metabolism in TM6SF2-knockdown cells; C: The SREBP-1c target protein
  levels in L02 and HepG2 cells after palmitic acid (PA) treatment; D: The SREBP-1c
  target protein levels in TM6SF2-knockdown cells after PA treatment; E: Immunoblot
  analysis of SREBP-1c in cytoplasmic and nuclear extracts; F: Hepatic malonyl-CoA
  contents of mice in two groups (n = 5 mice per group); G: The mRNA levels of genes
  involved in fatty acid synthesis (Srebf1, Fasn, Scd1, Acaca and Hmgcr) and uptake
  (Cd36, Slc27a1 and Fabp1). aP < 0.05; bP < 0.01; cP < 0.001. HFD: High-fat diet;
  PA: Palmitic acid; ACC: Acetyl-CoA carboxylase; μM: μmol/L.'
article_title: Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic
  fatty liver diseases via in vivo and in vitro experiments.
citation: Zu-Yin Li, et al. World J Gastroenterol. 2022 Jul 7;28(25):2937-2954.
year: '2022'

doi: 10.3748/wjg.v28.i25.2937
journal_title: World Journal of Gastroenterology
journal_nlm_ta: World J Gastroenterol
publisher_name: Baishideng Publishing Group Inc

keywords:
- TM6SF2
- Nonalcoholic fatty liver disease
- Fatty acid metabolism
- Treatment
- MK-4074

---
